Market Tracker

01/30 6:05pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

159.97
Data as of Jan 30
 -1.54 / -0.95%
Today’s Change
106.00
Today|||52-Week Range
162.80
+11.78%
Year-to-Date

Today’s Trading

Previous close161.51
Today’s open160.24
Day’s range158.35 - 161.73
Volume1,409,813
Average volume (3 months)2,145,396
Market cap$53.4B
Dividend yield--
Data as of 4:01pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)-610.53%
Earnings growth (this year)+33.16%
Earnings growth (next 5 years)+33.90%
Revenue growth (last year)+62.68%
P/E ratio--
Price/Sales6.53
Price/Book10.41

Competitors

 Today’s
change
Today’s
% change
SHPGShire-2.91-1.31%
AGNAllergan-3.13-1.41%
ABTAbbott Laboratories-0.50-1.10%
ALXNAlexion Pharmaceutic...-4.81-2.56%
Data as of 5:03pm ET, 01/30/2015

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)$2.55
Annual revenue (last year)$5.8B
Annual profit (last year)-$866.1M
Net profit margin-15.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts